Results 1 to 10 of about 684,976 (303)

Chronotropic incompetence in end-stage liver disease.

PLoS ONE, 2022
BackgroundCirrhosis causes alterations in the cardiovascular and autonomic nervous systems and leads to cirrhotic cardiomyopathy (CCM). CCM is defined as cardiac dysfunction characterized by an impaired systolic responsiveness to stress or exercise, and ...
Renata Główczyńska, Sonia Borodzicz-Jażdżyk, Michał Peller, Joanna Raszeja-Wyszomirska, Piotr Milkiewicz, Krzysztof Zieniewicz, Grzegorz Opolski   +6 more
doaj   +4 more sources

Liver Regeneration and Cell Transplantation for End-Stage Liver Disease

Biomolecules, 2021
Liver transplantation is the only curative option for end-stage liver disease; however, the limitations of liver transplantation require further research into other alternatives.
Yan Li, Lungen Lu, Xiaobo Cai
doaj   +3 more sources

Opportunistic infections in end stage liver disease

Infectious Disease Reports, 2018
Liver cirrhosis is the 10th most common cause of death in Western world and infection is associated with a high morbidity and mortality, and represents the leading cause of acute liver decompensation.
Michele Bartoletti, Maddalena Giannella, Sara Tedeschi, Pierluigi Viale   +3 more
doaj   +4 more sources

Association of mild-to-moderate Model for End-Stage Liver Disease scores on short-term cardiac surgery postoperative outcomesCentral MessagePerspective [PDF]

JTCVS Open
Objective: We assessed the Model for End-Stage Liver Disease score in patients with mild-moderate scores to predict perioperative outcomes in patients undergoing cardiac surgery.
Tom Liu, MD, MS, Zhanlin Chen, BS, MS, Ryan C. Jacobs, MD, MS, Charles D. Logan, MD, MS, Beth Whippo, MSN, RN, Seokyung An, PhD, Patrick M. McCarthy, MD, Christopher K. Mehta, MD   +7 more
doaj   +2 more sources

Evaluation of correlation between etiology of end stage liver disease and intraoperative utilization of blood products during liver transplantation [PDF]

Saudi Journal of Anaesthesia
Background: Liver transplantation is frequently associated with massive blood loss and utilization of blood products to optimize coagulation; this study aimed to evaluate their possible correlation with etiological and perioperative factors.
Amer Majeed, Basel A. Jobeir, Muhammad Shabbir, Mohammed Ibrahim, Mohamad S. Nagy, Bilal Tufail, Dimitri A. Raptis, Luluah Altukhaifi, Areej A. G. AlFattani   +8 more
doaj   +2 more sources

Model for end-stage liver disease-3.0 vs. model for end-stage liver disease-sodium: mortality prediction in Korea [PDF]

The Korean Journal of Internal Medicine
Background/Aims The model for end-stage liver disease (MELD) serves as an indicator for short-term mortality among patients diagnosed with liver cirrhosis (LC) and is used to prioritize patients for liver transplantation.
Jeong Han Kim, Yong Joon Cho, Won Hyeok Choe, So Young Kwon, Byung-Chul Yoo   +4 more
doaj   +2 more sources

Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease [PDF]

BMC Gastroenterology
Background and aims Intestinal paralysis is a common complication in end-stage liver disease (ESLD), our aim is to assess the effectiveness and safety of low-dose terlipressin for treating intestinal paralysis in ESLD.
Xia Wan, Hua Xu, Hu Li, Shan Zhong, Yu Lei, Huan Deng, Xiao Fu, Zhi Zhou   +7 more
doaj   +2 more sources

From Child-Pugh to MELD score and beyond: Taking a walk down memory lane

Annals of Hepatology, 2022
The Child-Turcotte-Pugh (CTP) and the MELD (Model for End-Stage Liver Disease) scores were designed to predict the outcome of decompressive therapy for portal hypertension.
Andres Ruf, Melisa Dirchwolf, Richard B. Freeman   +2 more
doaj   +1 more source

Palliative Care in Advanced Liver Disease: Similar or Different Palliative Care Needs in Patients with a Prospect of Transplantation? Prospective Study from a Portuguese University Hospital and Transplantation Center

GE: Portuguese Journal of Gastroenterology, 2023
Background and Aims: End-stage liver disease (ESLD) is an important cause of morbidity and mortality, comparable to a large extent to other organ insufficiencies. The need for palliative care (PC) in patients with ESLD is high.
Sara Neves Vieira da Silva, Patricia Baptista, Isabel Fonseca Silva, Elga Freire, Helena Pessegueiro Miranda   +4 more
doaj   +1 more source

Liver Transplantation for Alagille's Syndrome [PDF]

, 1993
Twenty-three children with Alagille's syndrome and end-stage liver disease underwent liver transplantation with cyclosporine and low-dose steroid immunosuppression. Two to 9 years (mean, 4.4 years) after surgery, 13 (57%) of the children were still alive,
Reyes, J, Starzl, TE, Tepetes, K, Todo, S, Tzakis, AG, Tzoracoleftherakis, V   +5 more
core   +1 more source